Bonnie Steinbock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Latest Publications
- Open Access
- 1 October 2008
- Published by Elsevier in The Lancet
- Vol. 372 (9646) , 1294-1295
Designer babies: choosing our children's genes
- 1 October 2008
- Published by Elsevier in The Lancet
- Vol. 372 (9646) , 1294-1295
Open AccessDesigner babies: choosing our children's genes
- 31 December 2007
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 15, 38-42
Prenatal testing for adult-onset conditions: cui bono?
- 31 December 2007
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 15, 38-42
Prenatal testing for adult-onset conditions: cui bono?
- 30 November 2005
- Published by Elsevier in Fertility and Sterility
- Vol. 84 (5) , 1551-1552
Do variations in assisted reproductive technology programs’ screening practices indicate a need for national guidelines? Another perspective
- 30 November 2005
- Published by Elsevier in Fertility and Sterility
- Vol. 84 (5) , 1551-1552
Do variations in assisted reproductive technology programs’ screening practices indicate a need for national guidelines? Another perspective
- Open Access
- 30 March 2005
- Published by BMJ in Journal of Medical Ethics
- Vol. 31 (4) , 235-241
The case for physician assisted suicide: not (yet) proven
The legalisation of physician assisted suicide (PAS) in Oregon and physician assisted death (PAD) in the Netherlands has revitalised the debate over whether and under what conditions individuals should be able to determine the time and manner of their deaths, and whether they should be able to enlist the help of physicians in doing so. Although the change in the law is both dramatic and recent, the basic arguments for and against have not really changed since the issue was debated by Glanville Williams and Yale Kamisar nearly 50 years ago. In this paper, the author argues in favour of Kamisar’s consequentialist framework. Any change in law and social policy should not be based solely on individual cases, heart wrenching though these may be. Instead, we need to assess the need for PAS, and weigh this against the risks of mistake and abuse.
- 30 March 2005
- Published by BMJ in Journal of Medical Ethics
- Vol. 31 (4) , 235-241
Open AccessThe case for physician assisted suicide: not (yet) proven
The legalisation of physician assisted suicide (PAS) in Oregon and physician assisted death (PAD) in the Netherlands has revitalised the debate over whether and under what conditions individuals should be able to determine the time and manner of their deaths, and whether they should be able to enlist the help of physicians in doing so. Although the change in the law is both dramatic and recent, the basic arguments for and against have not really changed since the issue was debated by Glanville Williams and Yale Kamisar nearly 50 years ago. In this paper, the author argues in favour of Kamisar’s consequentialist framework. Any change in law and social policy should not be based solely on individual cases, heart wrenching though these may be. Instead, we need to assess the need for PAS, and weigh this against the risks of mistake and abuse.
- 1 September 2004
- Vol. 71 (4) , 255-65
Payment for egg donation and surrogacy.
This article examines the ethics of egg donation. It begins by looking at objections to noncommercial gamete donation, and then takes up criticism of commercial egg donation. After discussing arguments based on concern for offspring, inequality, commodification, exploitation of donors, and threats to the family, I conclude that some payment to donors is ethically acceptable. Donors should not be paid for their eggs, but rather they should be compensated for the burdens of egg retrieval. Making the distinction between compensation for burdens and payment for a product has the advantages of limiting payment, not distinguishing between donors on the basis of their traits, and ensuring that donors are paid regardless of the number or quality of eggs retrieved.
- 1 September 2004
- Vol. 71 (4) , 255-65
Payment for egg donation and surrogacy.
This article examines the ethics of egg donation. It begins by looking at objections to noncommercial gamete donation, and then takes up criticism of commercial egg donation. After discussing arguments based on concern for offspring, inequality, commodification, exploitation of donors, and threats to the family, I conclude that some payment to donors is ethically acceptable. Donors should not be paid for their eggs, but rather they should be compensated for the burdens of egg retrieval. Making the distinction between compensation for burdens and payment for a product has the advantages of limiting payment, not distinguishing between donors on the basis of their traits, and ensuring that donors are paid regardless of the number or quality of eggs retrieved.